UK becomes first country to approve Pfizer’s Covid-19 vaccine


ISLAMABAD, December 2 (online): Drugmaker Pfizer and its German partner BioNTech have been granted temporary authorization for emergency use of their Covid-19 vaccine in the UK, the companies announced.
This marks the first time that citizens outside of the worldwide clinical trials will have the opportunity to be immunized against Covid-19, according to BioNTech CEO Ugur Sahin.
The vaccine will be made available across the UK starting next week, a spokesperson from the Department of Health and Social Care said in a statement. More details will be released soon, including advice for priority groups like the elderly and health care staff to receive the vaccine.
“To aid the success of the vaccination programme it is vital everyone continues to play their part and abide by the necessary restrictions in their area so we can further suppress the virus and allow the NHS to do its work without being overwhelmed,” the spokesperson said.
Pfizer and BioNTech previously said that analysis of the vaccine showed it was 95% effective with no safety concerns.